April 25 Lecture: Kratom’s Therapeutic Potential in Opioid Addiction

Can a controversial tree help end the opioid crisis? Insights on that question will be offered in a virtual lecture on April 25 launching the spring 2022 season of the National Center for Complementary and Integrative Health’s Integrative Medicine Research Lecture Series.

Dr. Christopher R. McCurdy, the Frank A. Duckworth Eminent Scholar Chair in Drug Research and Development and a professor of medicinal chemistry at the University of Florida (UF) College of Pharmacy, will explore kratom—both as a traditional medicinal treatment in Southeast Asia and, increasingly, a subject of published studies over the past few years around its potential to help treat opioid addiction and withdrawal.

April 25 Lecture: Kratom’s Therapeutic Potential in Opioid Addiction

Chris McCurdy in his lab at the University of Mississippi School of Pharmacy. (UM photo by Kevin Bain)

Kratom Lords  >  Kratom University  >  Kratom News  >  April 25 Lecture: Kratom Therapeutic Opioid Addiction ​

Join the Kratom Lords Family

Sign up to get 10% off on your first order. Stay updated on the latest deals, flash sales, latest Kratom news and more!

Dr. McCurdy is an internationally recognized expert on kratom who also directs the UF Translational Drug Development Core. His lecture, “Can a Controversial Tree Help End the Opioid Crisis?” will be streamed on Monday, April 25, from 1 to 2 p.m. ET on NIH VideoCast and Facebook. No registration is necessary, and we invite all interested persons inside and outside the National Institutes of Health. The lecture will also be archived on the above sites.

As a brief overview: Kratom (Mitragyna speciosa Korth) is a tree in the coffee family (Rubiaceae) indigenous to Southeast Asia. Its leaves are the source of a Thai traditional drug, kratom, with unique pharmacologic actions—e.g., both stimulant and depressant actions. Kratom has been used traditionally in Southeast Asia as an opioid substitute and in Thailand as a treatment for addiction. Little was known scientifically, however, about this tree and drug.

In the past few years, more study results and human case reports have started to appear in the literature, and the U.S. Drug Enforcement Administration has listed kratom as a Drug and Chemical of Concern. Dr. McCurdy will discuss the traditional medicinal use of kratom, examples of current pharmacologic studies, and results of his team’s behavioral studies in rodent models. The potential of kratom and its major alkaloid (mitragynine) in the context of opioid addiction and withdrawal will be the primary focus.

Dr. McCurdy’s research centers on the design, synthesis, and development of drugs to treat pain and drug abuse, often involving discovery chemistry with opioid receptors, neuropeptide FF (NPFF) receptors, and sigma receptors.

We hope you can join us for this online event (again, registration is not necessary). Information about the next two lectures will be posted as available, and promoted through this blog.

Source: National Center for Complementary and Integrative Health


The above article is a repost. Please refer to the source provided to go to the original article. Kratomlords.com, it’s holding company, and it’s owners do not endorse any published content provided herein.

Kratomlords.com strongly recommends following FDA guidelines regarding Kratom. Please refer to the following link for further information. www.fda.gov/news-events/public-health-focus/fda-and-kratom

Leave a Comment


No comments yet. Why don’t you start the discussion?

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    WAAVE Compliance